Earl Martin Douglas, General Counsel at BIOMIMETIC THERAPEUTICS, INC. (BMTI), sold 12,000 shares at $3.01 ($36K) on 2011-10-11, disclosed to the SEC on 2011-10-11.
Scheduled sale ($36k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.99 | 3,000 | $9K | 24.9% |
| 2 | $3.02 | 3,000 | $9K | 25.2% |
| 3 | $2.97 | 3,000 | $9K | 24.8% |
| 4 | $3.01 | 3,000 | $9K | 25.1% |
| Total | $3.00 avg | 12,000 | $36K | 100% |
| Filing → |
| ALLO | SELL | 2025-02-05 | $11K | — | Filing → |
| BMTI | SELL | 2012-03-28 | $126K | — | Filing → |
| BMTI | SELL | 2011-10-14 | $27K | — | Filing → |